AstraZeneca
A Senior Leadership role in Oncology R&D at AstraZeneca focusing on drug discovery in small molecule portfolio. The role involves strategic leadership, portfolio prioritization, and cross-functional collaboration to shape oncology strategy and decision making.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
74% above the average for this role
Executive Director, Head of US Bioscience, Small Molecules, Oncology Targeted Discovery
American Association of Physicists in Medicine
Director, Discovery Oncology, Small Molecules
MSD
Senior/ Executive Director, Discovery-Oncology
Johnson & Johnson Medical Korea Limited
Principal Scientist, Oncology Drug Discovery
GSK plc
Oncology Small Molecule Pipeline Lead
Merck & Co., Inc.
VP/SVP Drug Discovery
Acrivon Therapeutics